2017: Fitzpatrick Voted Against Exempting Regulations That Will Result
In Fewer Cancer Incidents Or Respiratory Death In Children Or The
Elderly From Legislation That Would Add Requirements For How Federal
Rules Are Made. In January 2017, Fitzpatrick voted against an
amendment that would have, according to Congressional Quarterly,
"exempt[ed] rules that will result in reduced incidence of cancer,
early death or respiratory disease among children or seniors. It would
[have] remove[d] the bill's provision that would effectively
overturn two Supreme Court decisions that require federal courts to
defer to an agency's interpretation of the underlying law or rule when
considering challenges to agency rules." The underlying legislation,
also according to Congressional Quarterly, "would modify the federal
rule-making process, including by codifying requirements for agencies to
consider costs and benefits of alternatives. The bill would create
additional steps that agencies would need to follow when planning
'major' rules with annual costs of more than $100 million or
'high-impact' rules with annual costs of more than $1 billion." The
vote was on the amendment. The House rejected the amendment by a vote of
189 to 231. [House Vote 37,
1/11/17; Congressional
Quarterly, 1/11/17; Congressional
Quarterly, 1/11/17; Congressional
Actions, H. Amdt.
23;
Congressional Actions, H.R.
5]